Terveystalo

8.11 EUR

-1.22 %

12,230 following

TTALO

NASDAQ Helsinki

Medical Equipment & Services

Health Care

-1.22 %
+6.71 %
-12.98 %
-17.08 %
-13.54 %
-33.42 %
-0.61 %
-31.27 %
-18.90 %

Terveystalo operates in the healthcare sector. The company offers services and solutions such as surveys and examinations, training and coaching, rehabilitation, and health and fitness mapping. Its customers include small and medium-sized corporate customers, as well as public sector players. The head office is located in Helsinki.

Read more
Market cap
1.03B EUR
Turnover
2.04M EUR
P/E (adj.) (26e)
11.44
EV/EBIT (adj.) (26e)
11.86
P/B (26e)
1.78
EV/S (26e)
1.3
Dividend yield-% (26e)
6.17 %
Coverage
Recommendation
Reduce
Target price
7.90 EUR
Updated
26.04.2026
Disclaimer
Roni Peuranheimo
Roni Peuranheimo

Analyst

Latest research

Latest analysis report

Released: 27.04.2026

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7
2026

Interim report Q2'26

7.10
2026

Half year dividend

21.10
2026

Interim report Q3'26

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
This same narrative has been repeated for 6 years now, since I bought this after the Covid dip because it “hadn’t risen with the rest of the market YET.” It has proven to be a weak investment, sector, and company.
4/24/2026, 11:12 AM
by keso25
14
Here is the company report from Joni after Q1. Terveystalo’s Q1 results fell clearly short of both our and consensus expectations, with the demand situation in the private health services market being historically weak. The company reiterated its guidance, which relies on gradually...
4/27/2026, 6:02 AM
by Sijoittaja-alokas
11
Fees are being raised right now. Various savings are in store. Directly impacting people’s wallets are, for example, new client and procedure fees as well as various increases: Client fee for special examinations: €52.40 Surgery and procedure fee: €257.20 (in addition to the inpatient...
4/24/2026, 8:50 AM
by Blackparta
11
The operating environment is not easy at the moment, but it cannot be blamed for everything. @JaKu mentioned their experiences above from a practitioner’s perspective and described the treatment at Terveystalo as blunt compared to other large players. The Q1 report shows that occupational...
4/24/2026, 7:51 AM
by LaskuPutki
10
Here is Juho Toratti’s analysis of Terveystalo following Q1 At the earnings call, Terveystalo’s management stated that the company estimates that the market bottoms are already behind them. According to CFO Juuso Pajunen, this assessment is based on the company’s internal data, such...
4/25/2026, 7:38 AM
by Sijoittaja-alokas
9
Roni interviewed Terveystalo CEO Ville Iho regarding Q1 Inderes Terveystalo Q1’26: “Nahkea markkina” - Inderes Aika: 24.04.2026 klo 14.10 Terveystalon liiketoimintaan tarttui alkuvuodesta flunssa myynnin ja tuloksen nuupahtaessa. Topics: 00:00 Start of the year 01:00 Cycle vs. structural...
4/24/2026, 2:38 PM
by Sijoittaja-alokas
8
Matti’s clients vanished – ”No one needs them” Occupational health psychologist Matti Jaakkola says that the number of clients in occupational health care has decreased during this year. According to him, AI is one reason for this somewhat surprising development.
4/25/2026, 3:48 AM
by Jukka
7
Read more on our forum

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.